Roche Stamm Logo

Roche Stamm

🇨🇭
RO
CH0012032113

Roche Stamm is a globally leading biotechnology company headquartered in Switzerland. It focuses on the research and development of innovative pharmaceuticals and diagnostics. The objective is to create groundbreaking therapies and solutions that sustainably improve patients' lives, positioning Roche Stamm at the forefront of medical advancements.

Next Quarterly Earnings

Thursday, October 22, 2026
CW 43
Pre-Market
In 56 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Quiet period starts on September 24, 2026

Stock Price

Recap: the latest results

Roche Stamm (RO) reported its Q2 2026 financial results on July 23, 2026, before the market opened. The company reported an EPS of 10.85 CHF, beating the analyst estimate of 10.33 CHF by 5.0%. Revenue for the quarter reached 15642 million CHF, and the stock price rose by 5.15% following the announcement.

Generated automatically from our data — as of 07/29/2026 Read the article →

Frequently asked questions

When will Roche Stamm report its next quarterly earnings?

Roche Stamm is scheduled to report its next quarterly earnings on 10/22/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

When did Roche Stamm last report quarterly earnings?

Roche Stamm last reported quarterly earnings on 7/23/2026 (Q2 2026). Earnings per share (EPS) came in at 10.85 CHF.

How does Roche Stamm stock react to earnings?

Across its last 5 earnings reports, Roche Stamm stock moved by ±3% on average the following day. The largest reaction was +5.2% on 07/23/2026; 4 of 5 reactions were positive.

Does Roche Stamm pay a dividend?

For fiscal year 2025, Roche Stamm paid a dividend of 9.80 CHF per share.

How do I add the Roche Stamm earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q3 2026
Estimate:
Actual:
Q2 2026
Beat
Estimate:CHF 10.33
Actual:CHF 10.85
Difference:+CHF 0.52
Price reaction (1 day):+5.2 %
Price reaction (7 days):+6.2 %
Q1 2026
Estimate:
Actual:
Price reaction (1 day):+3.2 %
Price reaction (7 days):+0.9 %
Q4 2025
Estimate:
Actual:CHF 8.38
Price reaction (1 day):+1.8 %
Price reaction (7 days):+5.7 %
Q3 2025
Estimate:
Actual:
Price reaction (1 day):-3.5 %
Price reaction (7 days):-6.5 %
Q4 2024
Estimate:
Actual:
Price reaction (1 day):+1.5 %
Price reaction (7 days):+2.3 %

Earnings statistics

Stock reaction to earnings

±3%
Avg. next-day move
+5.2%
Largest move (07/23/2026)
80%
Share of positive reactions
±4.3%
Avg. move after 7 days

Basis: price reactions to the last 5 report dates (close to close).

Past price reactions are not a reliable indicator of future performance.

Dividend history

9.80 CHF
Last dividend (FY 2025)
5
Fiscal years covered
Fiscal yearDividend per shareEx-datePayment date
2025 9.80 CHF3/12/20263/16/2026
2024 9.70 CHF3/27/20253/31/2025
2023 9.60 CHF
2022 9.50 CHF
2021 9.30 CHF

Source: Roche Stamm investor relations, 5 fiscal years.

Past dividends are no guarantee of future payouts.

Company Information

Name
Roche Stamm
Ticker Symbol
RO
ISIN
CH0012032113
Country
🇨🇭
Switzerland
Sector
More Financial Information